The key to the #commercialization journey is actually in developing relationships with stakeholders through an understanding of priorities, rather than trying to be an expert in all areas. #regenmed #commercialization @MTPConnect_AUS
It was useful to catch up with @BlueRockTx, @CGTCatapult and @CCRM_ca at the @ISSCR meeting in Toronto today. Three important participants in the iPSC #Quality Round 2019.
Fate Tx opens new GMP facility for iPSC therapeutic development
Fate Therapeutics Announces the Opening of its cGMP Manufacturing Facility Dedicated to iPSC-derived Cell Therapies | Fate Therapeutics, Inc.
The Investor Relations website contains information about Fate Therapeutics, Inc.'s business for stockholders, potential investors, and financial anal...
At the MARS Centre at the University of Toronto today, visiting @CCRM and holding discussions with other Canadian Participants of the iPSC Quality Round 2019 today and tomorrow.
Congrats @StemCellNetwork for another successful TMM. As always, it is wonderful to work with you on the meeting. Thanks to all speakers and attendees. See you next year!
Stem Cell Network on Twitter
“#TMM2019 has officially concluded! Thank you to our co-host @CCRM_ca and to all our generous sponsors!!! We hope to see you all in Vancouver fo...
Regulated, Reputable & Reliable how #stemcell treatments should be developed with proper regulatory oversight around the world #TMM2019 @StemCellNetwork nice overview from Health Canada
Thanks to CellCAN for a useful workshop on iPSC quality and standardization at Till McCulloch 2019 Meeting in Montréal today.
GAiT Director & CCRM CEO Michael May opens the Till McCulloch Meeting 2019 in Montréal
Come join us at the CellCAN interactive workshop at #TMM2019 in Montreal on Nov. 4. #celltherapy #stemcells
Only a few days away from our annual #workshop at the #TMM2019. This year, we are proud to host a panel of experts that will be discussing International consensus-built QC guidelines for iPSC and those developed here in Canada. @IPSCtherapies @TheNeuro_MNI @STEMCELLTech
Now hearing from Jun Takahashi of @KyotoU_News on his clinical trial for #Parkinsons using iPSC-derived dopamine neurons #NYSCF19
Gender equality in #STEM is incredibly important to me, and to all of us at @nyscf. We welcome partners in our journey to level the field, please reach out if you too want to change the landscape! #WomeninStem
New York Stem Cell Foundation Research Institute on Twitter
“#GenderEquality in #STEM is mission critical for NYSCF, because we need all of the brightest minds in the field to accelerate life-saving disco...
GAiT Director Susan Solomon introduces Nobel Laureate Prof Shinya Yamanaka at #NYSCF2019 annual conference this morning.
GAiT is at the annual NYSCF conference at Rockefeller University today and tomorrow. We are enjoying catching up with our American members.
GAiT will be attending the NYSCF annual conference in New York this Tuesday and Wednesday (22nd and 23rd October 2019). See program here
The NYSCF Conference - New York Stem Cell Foundation
The NYSCF Conference is the leading scientific meeting on translational stem cell research. It...
GAiT director Dr Jacqueline Barry talking about AMTP regulatory consequences of Brexit
Thanks to the organizers of Phacilitate Leaders Asia & World Stem Cell Summit - China for a good conference. We look forward to continue working with our Chinese members.
En route to Shanghai to speak about the iPSC Quality Round at Phacilitate Leaders Asia / World Stem Cell Summit - China http://www.phacilitate-leaders-asia.com
GAiT will be speaking in Shanghai this week about the induced Pluripotent Stem Cell Quality Round 2019 and how participation in such activity makes translation to the clinic more efficient. More at https://www.phacilitate-leaders-asia.com/